In an effort to foster the local bioscience industry, the South Louisiana Institute for Infectious Disease Research (SLIIDR), the Louisiana Vaccine Center (LVC) and the Clinical and Translational Research, Education and Commercialization Project (CTRECP) (all Joint LSU – Tulane Health Sciences Center initiatives) have joined forces with the New Orleans BioInnovation Center (NOBIC) to develop a systematic approach for transforming new discoveries into viable business opportunities. This consolidated commercialization strategy will provide the necessary catalyst to jumpstart bioscience entrepreneurship in New Orleans.

     In collaboration with NOBIC, student interns will assess and support the commercialization of locally developed health-sciences related products and processes. Data obtained from this processwill be housed in a comprehensive database designed to streamline the flow of information between researchers, universities, businesses and venture capitalists.

     After a thorough market and competitor analysis, a team of experienced researchers and business leaders will determine a development path that may include licensing technology or spinning off a start-up company.  New ventures will receive support in a number of areas including business plan development, raising capital and hiring management.

     The combined commercialization strategy will ultimately assist in strengthening and creating new partnerships between the research institutions and existing biotech companies, and nurturing bioscience entrepreneurship among local students.

     For more information about the commercialization strategy, please contact Steve Ceulemans at stevenc@neworleansbio.com.